Andrés Herrera-Yela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrés Herrera-Yela has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Isaac Armendáriz-Castillo
Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), 28001 Madrid, Spain
4 shared publications - Jaime David Acosta-España
Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador
4 shared publications - Alexander Maldonado
Biomedical Sciences, Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito, Ecuador
3 shared publications - Andrés Carrazco-Montalvo
Instituto de Microbiología, Universidad San Francisco de Quito, Ecuador
3 shared publications - Andrés López-Cortés
Cancer Research Group (CRG), Faculty of Medicine, Universidad de las Américas
3 shared publications - Damaris Alarcón-Vallejo
Instituto Nacional de Investigación en Salud Pública "Leopoldo Izquieta Pérez". Centro de Referencia Nacional de Genómica, Secuenciación y Bioinformática
3 shared publications
Latest Publications
- Open Access
Deconstructing the Alternative Lengthening of Telomeres: Integromics Prioritizes Five Master Hubs Dictating Clinical Survival and Therapeutic Vulnerabilities
The Alternative Lengthening of Telomeres (ALT) pathway drives replicative immortality in aggressive malignancies, particularly sarcomas and gliomas. Clinical ALT stratification has relied on screening for structural ATRX and DAXX mutations. However, this genotypic approach fails to capture the dynamic macro-reprogramming required to sustain ALT. Here, we established and validated a 28-gene transcriptomic signature that captures the ALT-associated transcriptomic phenotype of the ALT phenotype. Using multivariate Cox proportional hazards models and time-dependent ROC analyses, we demonstrate that this signature is a robust, independent predictor of poor overall survival in Sarcoma (SARC) and Lower Grade Glioma (LGG) cohorts, outperforming the prognostic value of traditional ATRX/DAXX mutational status. Genomic mapping revealed this transcriptional synchrony is structurally facilitated by non-random focal clustering on Chromosome 8. To deconstruct the machinery driving this lethal phenotype, we employed an integromic approach, synthesizing protein–protein and metabolic flux networks. Topological algorithms prioritized five indispensable hubs: TP53, ATM, ATR, PCNA, and UBE2I. Gene–metabolite profiling identified PCNA as a bottleneck funneling extreme deoxyribonucleotide (dNTP) demand to sustain break-induced telomeric recombination. To translate these vulnerabilities into actionable treatments, we mapped these hubs to a precision pharmacological network. We propose a multi-targeted strategy combining FDA-approved PARP inhibitors to exploit ATR-mediated synthetic lethality, alongside antimetabolites to induce nucleotide starvation. This study redefines ALT risk stratification and provides a data-driven framework to target and treat resistant ALT-positive tumors.
Open AccessDeconstructing the Alternative Lengthening of Telomeres: Integromics Prioritizes Five Master Hubs Dictating Clinical Survival and Therapeutic Vulnerabilities
The Alternative Lengthening of Telomeres (ALT) pathway drives replicative immortality in aggressive malignancies, particularly sarcomas and gliomas. Clinical ALT stratification has relied on screening for structural ATRX and DAXX mutations. However, this genotypic approach fails to capture the dynamic macro-reprogramming required to sustain ALT. Here, we established and validated a 28-gene transcriptomic signature that captures the ALT-associated transcriptomic phenotype of the ALT phenotype. Using multivariate Cox proportional hazards models and time-dependent ROC analyses, we demonstrate that this signature is a robust, independent predictor of poor overall survival in Sarcoma (SARC) and Lower Grade Glioma (LGG) cohorts, outperforming the prognostic value of traditional ATRX/DAXX mutational status. Genomic mapping revealed this transcriptional synchrony is structurally facilitated by non-random focal clustering on Chromosome 8. To deconstruct the machinery driving this lethal phenotype, we employed an integromic approach, synthesizing protein–protein and metabolic flux networks. Topological algorithms prioritized five indispensable hubs: TP53, ATM, ATR, PCNA, and UBE2I. Gene–metabolite profiling identified PCNA as a bottleneck funneling extreme deoxyribonucleotide (dNTP) demand to sustain break-induced telomeric recombination. To translate these vulnerabilities into actionable treatments, we mapped these hubs to a precision pharmacological network. We propose a multi-targeted strategy combining FDA-approved PARP inhibitors to exploit ATR-mediated synthetic lethality, alongside antimetabolites to induce nucleotide starvation. This study redefines ALT risk stratification and provides a data-driven framework to target and treat resistant ALT-positive tumors.
- Open Access
- 22 April 2026
- Published by APESC - Associacao Pro-Ensino em Santa Cruz do Sul in Revista de Epidemiologia e Controle de Infecção
- Vol. 16
Infecciones por protozoos en Ecuador, vigilancia de la salud pública y prioridades de investigación, 2016-2023: una revisión del alcance
Background and Objectives: Protozoal parasitic infections continue to impact public health in Ecuador, as reflected in reports indicating increases in malaria cases, a moderate presence of leishmaniasis, and the continued endemic status of Chagas disease. This underscores the need to focus policy and research efforts. The objective of this review was to synthesize recent evidence on the detection, diagnosis, and epidemiology of protozoal infections in Ecuador (2016-2023) to guide surveillance and research priorities. Content: Scoping review with searches in PubMed, SCOPUS, and SciELO (Mar-Jul 2024), following PRISMA-ScR and Joanna Briggs Institute (JBI) steps. We included studies conducted in Ecuador, in humans, animals, and the environment, that employed laboratory tests. We extracted species/genus, provincial location, sample type/population, and diagnostic technique. The base protocol was registered in OSF (https://osf.io/8vuc3). Of 1,180 records, 98 studies met the criteria. Most focused on Leishmania spp. and intestinal protozoa, with an increase in agent diversity since 2020 and inclusion of environmental samples. Molecular and serological methods were frequently used, with emphasis on vulnerable populations. Pichincha and Guayas concentrated the widest variety of genera studied, whereas Amazonian provinces had fewer studies. Nationally, Leishmania spp. and Plasmodium spp. were reported in 23 and 17 provinces, respectively. Conclusion: Studies on vectors and reservoirs, spillover, and zoonotic transmission must be strengthened. Research should be expanded in rural and Amazonian areas, and active surveillance should be maintained, incorporating sequencing and integrated “One Health” approaches.
- 22 April 2026
- Published by APESC - Associacao Pro-Ensino em Santa Cruz do Sul in Revista de Epidemiologia e Controle de Infecção
- Vol. 16
Open AccessInfecciones por protozoos en Ecuador, vigilancia de la salud pública y prioridades de investigación, 2016-2023: una revisión del alcance
Background and Objectives: Protozoal parasitic infections continue to impact public health in Ecuador, as reflected in reports indicating increases in malaria cases, a moderate presence of leishmaniasis, and the continued endemic status of Chagas disease. This underscores the need to focus policy and research efforts. The objective of this review was to synthesize recent evidence on the detection, diagnosis, and epidemiology of protozoal infections in Ecuador (2016-2023) to guide surveillance and research priorities. Content: Scoping review with searches in PubMed, SCOPUS, and SciELO (Mar-Jul 2024), following PRISMA-ScR and Joanna Briggs Institute (JBI) steps. We included studies conducted in Ecuador, in humans, animals, and the environment, that employed laboratory tests. We extracted species/genus, provincial location, sample type/population, and diagnostic technique. The base protocol was registered in OSF (https://osf.io/8vuc3). Of 1,180 records, 98 studies met the criteria. Most focused on Leishmania spp. and intestinal protozoa, with an increase in agent diversity since 2020 and inclusion of environmental samples. Molecular and serological methods were frequently used, with emphasis on vulnerable populations. Pichincha and Guayas concentrated the widest variety of genera studied, whereas Amazonian provinces had fewer studies. Nationally, Leishmania spp. and Plasmodium spp. were reported in 23 and 17 provinces, respectively. Conclusion: Studies on vectors and reservoirs, spillover, and zoonotic transmission must be strengthened. Research should be expanded in rural and Amazonian areas, and active surveillance should be maintained, incorporating sequencing and integrated “One Health” approaches.
- Open Access
- 4 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11750
Calmodulin Interaction Interface with Plasma Membrane Ca2+-ATPase Isoforms: An Integrative Bioinformatic Analysis
Plasma membrane Ca2+-ATPases (PMCA) are activated by calmodulin (CaM) via a C-terminal calmodulin-binding domain, CaMBD. Although specific mutations in this domain have been linked to disease, the broader impact of alternative substitutions across the interface remains unexplored. We applied an integrative in silico workflow to test six substitutions within CaMBD positions 1–18, L5R, N6I, I8T, V14E/D, and F18S, across PMCA isoforms 1–4. CaMBD sequences were aligned across isoforms, and candidates for substitutions were selected by conservation and nucleotide feasibility, prioritizing conserved or co-evolutionarily relevant sites, with substitutions possible by single-nucleotide change. PolyPhen-2 screened the impact of the substitutions on the protein functionality, the DisGeNET database was used to contextualize ATP2B genes with clinical phenotypes, and structural models plus binding free energy changes were estimated with AlphaFold3, FoldX, and MutaBind2. Effects were isoform and subregion dependent, with the strongest weakening toward the CaMBD C-terminus. V14E/D and F18S showed the largest and consistent predicted destabilization, consistent with disruption of conserved hydrophobic anchors. I8T and L5R had mixed outcomes depending on isoform, while N6I presented various scenarios with no clear effect. PolyPhen-2 classified most tested substitutions as damaging. Gene-disease evidence linked ATP2B to neurological, endocrine, and oncologic phenotypes, consistent with roles in Ca2+ homeostasis. Overall, CaMBD appears highly sensitive to perturbation, with distal positions 14–18 particularly vulnerable to substitutions that can destabilize CaM binding and potentially impair PMCA-mediated Ca2+ clearance in susceptible tissues.
- 4 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11750
Open AccessCalmodulin Interaction Interface with Plasma Membrane Ca2+-ATPase Isoforms: An Integrative Bioinformatic Analysis
Plasma membrane Ca2+-ATPases (PMCA) are activated by calmodulin (CaM) via a C-terminal calmodulin-binding domain, CaMBD. Although specific mutations in this domain have been linked to disease, the broader impact of alternative substitutions across the interface remains unexplored. We applied an integrative in silico workflow to test six substitutions within CaMBD positions 1–18, L5R, N6I, I8T, V14E/D, and F18S, across PMCA isoforms 1–4. CaMBD sequences were aligned across isoforms, and candidates for substitutions were selected by conservation and nucleotide feasibility, prioritizing conserved or co-evolutionarily relevant sites, with substitutions possible by single-nucleotide change. PolyPhen-2 screened the impact of the substitutions on the protein functionality, the DisGeNET database was used to contextualize ATP2B genes with clinical phenotypes, and structural models plus binding free energy changes were estimated with AlphaFold3, FoldX, and MutaBind2. Effects were isoform and subregion dependent, with the strongest weakening toward the CaMBD C-terminus. V14E/D and F18S showed the largest and consistent predicted destabilization, consistent with disruption of conserved hydrophobic anchors. I8T and L5R had mixed outcomes depending on isoform, while N6I presented various scenarios with no clear effect. PolyPhen-2 classified most tested substitutions as damaging. Gene-disease evidence linked ATP2B to neurological, endocrine, and oncologic phenotypes, consistent with roles in Ca2+ homeostasis. Overall, CaMBD appears highly sensitive to perturbation, with distal positions 14–18 particularly vulnerable to substitutions that can destabilize CaM binding and potentially impair PMCA-mediated Ca2+ clearance in susceptible tissues.
- Open Access
- 23 June 2025
- Published by MDPI AG in Preprints.org
Detection of Pulmonary Toxoplasma gondii Causing Atypical Pneumonia in an Immunosuppressed Patient through Metagenomic Sequencing
Background Pulmonary toxoplasmosis is a rare but critical opportunistic infection in immunosuppressed individuals, often presenting as atypical pneumonia. Conventional diagnostic methods, including serology and cultures, may yield false negatives, complicating timely diagnosis and treatment. Methods: A bronchoalveolar lavage sample was obtained from a 48-year-old immunosuppressed patient hospitalized with atypical pneumonia. The sample underwent next-generation sequencing (NGS)-based metagenomic analysis, including nucleic acid extraction, library preparation, high-throughput sequencing, and bioinformatic pipeline processing for microbial identification. Results: NGS identified Toxoplasma gondii DNA in the bronchoalveolar lavage sample, confirming a diagnosis of pulmonary toxoplasmosis. Remarkably, the patient responded clinically to metronidazole monotherapy, achieving significant symptom resolution. Follow-up computed tomography revealed complete radiological improvement, confirming clinical cure. Discussion: This case underscores the value of metagenomic sequencing in diagnosing atypical pathogens where conventional approaches fail. The identification of Toxoplasma gondii highlights the expanded utility of NGS in pulmonary infections, particularly in immunosuppressed patients. The unexpected success of metronidazole as a sole treatment raises questions about its potential efficacy against Toxoplasma gondii, warranting further investigation. Conclusion: Metagenomic diagnostics represent a powerful tool in identifying rare infectious agents and guiding effective interventions. This case highlights the clinical significance of NGS in improving diagnostic precision and broadening therapeutic horizons for pulmonary toxoplasmosis.
- 23 June 2025
- Published by MDPI AG in Preprints.org
Open AccessDetection of Pulmonary Toxoplasma gondii Causing Atypical Pneumonia in an Immunosuppressed Patient through Metagenomic Sequencing
Background Pulmonary toxoplasmosis is a rare but critical opportunistic infection in immunosuppressed individuals, often presenting as atypical pneumonia. Conventional diagnostic methods, including serology and cultures, may yield false negatives, complicating timely diagnosis and treatment. Methods: A bronchoalveolar lavage sample was obtained from a 48-year-old immunosuppressed patient hospitalized with atypical pneumonia. The sample underwent next-generation sequencing (NGS)-based metagenomic analysis, including nucleic acid extraction, library preparation, high-throughput sequencing, and bioinformatic pipeline processing for microbial identification. Results: NGS identified Toxoplasma gondii DNA in the bronchoalveolar lavage sample, confirming a diagnosis of pulmonary toxoplasmosis. Remarkably, the patient responded clinically to metronidazole monotherapy, achieving significant symptom resolution. Follow-up computed tomography revealed complete radiological improvement, confirming clinical cure. Discussion: This case underscores the value of metagenomic sequencing in diagnosing atypical pathogens where conventional approaches fail. The identification of Toxoplasma gondii highlights the expanded utility of NGS in pulmonary infections, particularly in immunosuppressed patients. The unexpected success of metronidazole as a sole treatment raises questions about its potential efficacy against Toxoplasma gondii, warranting further investigation. Conclusion: Metagenomic diagnostics represent a powerful tool in identifying rare infectious agents and guiding effective interventions. This case highlights the clinical significance of NGS in improving diagnostic precision and broadening therapeutic horizons for pulmonary toxoplasmosis.
- Open Access
- 25 March 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (7) , 102765
The epidemiology and clinical manifestations of anaplasmosis in humans: A systematic review of case reports
- 25 March 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (7) , 102765
Open AccessThe epidemiology and clinical manifestations of anaplasmosis in humans: A systematic review of case reports
- Open Access
- 21 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0314012
Metabolic pathways of Alternative Lengthening of Telomeres in pan-carcinoma
Alternative Lengthening of Telomeres (ALT) is a telomerase-independent mechanism deployed by several aggressive cancers to maintain telomere length. This contributes to their malignancy and resistance to conventional therapies. In prior studies, we have identified key proteins linked to the ALT process using multi-omic data integration strategies. In this work, we combined metabolomic datasets with our earlier results to identify targetable metabolic pathways for ALT-positive tumors. 39 ALT-related proteins were found to interact with 42 different metabolites in our analysis. Additional networking analysis revealed a complex interaction between metabolites and ALT-related proteins, suggesting that pan-cancer oncogenes may have an impact on these pathways. Three metabolic pathways have been primarily related with the ALT mechanism: purine metabolism, cysteine and methionine metabolism, and nicotinate and nicotinamide metabolism. Lastly, we prioritized FDA-approved drugs (azathioprine, thioguanine, and mercaptopurine) that could target ALT-positive tumors through purine metabolism. This work provides a wide perspective of the metabolomic pathways associated with ALT and reveals potential therapeutic targets that require further experimental validation.
- 21 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0314012
Open AccessMetabolic pathways of Alternative Lengthening of Telomeres in pan-carcinoma
Alternative Lengthening of Telomeres (ALT) is a telomerase-independent mechanism deployed by several aggressive cancers to maintain telomere length. This contributes to their malignancy and resistance to conventional therapies. In prior studies, we have identified key proteins linked to the ALT process using multi-omic data integration strategies. In this work, we combined metabolomic datasets with our earlier results to identify targetable metabolic pathways for ALT-positive tumors. 39 ALT-related proteins were found to interact with 42 different metabolites in our analysis. Additional networking analysis revealed a complex interaction between metabolites and ALT-related proteins, suggesting that pan-cancer oncogenes may have an impact on these pathways. Three metabolic pathways have been primarily related with the ALT mechanism: purine metabolism, cysteine and methionine metabolism, and nicotinate and nicotinamide metabolism. Lastly, we prioritized FDA-approved drugs (azathioprine, thioguanine, and mercaptopurine) that could target ALT-positive tumors through purine metabolism. This work provides a wide perspective of the metabolomic pathways associated with ALT and reveals potential therapeutic targets that require further experimental validation.
- Open Access
Mpox Vaccine Design Through Immunoinformatics and Computational Epitope Prediction
The Mpox virus (Monkeypox virus) poses significant public health risks due to its potential for severe outbreaks in humans. This study presents an innovative vaccine design using bioinformatics to identify epitopes that activate helper T cells (HTLs) via the human leukocyte antigen class II (HLA-II) complex. Starting with 50,040 vaccine candidates, 14 epitopes with the highest HLA-II affinity were selected based on antigenicity, allergenicity, toxicity, stability, and homology. These epitopes were integrated into a multi-epitope vaccine with spacers and adjuvants to enhance the immune response. A 3D model was developed, confirming structural stability and optimal epitope exposure through molecular dynamics simulations. The results indicate that the vaccine can induce robust immune responses, suggesting its potential effectiveness against the Mpox virus. Additionally, population coverage analysis supports its promise as a significant tool for controlling Mpox epidemics and advancing global public health initiatives.
Open AccessMpox Vaccine Design Through Immunoinformatics and Computational Epitope Prediction
The Mpox virus (Monkeypox virus) poses significant public health risks due to its potential for severe outbreaks in humans. This study presents an innovative vaccine design using bioinformatics to identify epitopes that activate helper T cells (HTLs) via the human leukocyte antigen class II (HLA-II) complex. Starting with 50,040 vaccine candidates, 14 epitopes with the highest HLA-II affinity were selected based on antigenicity, allergenicity, toxicity, stability, and homology. These epitopes were integrated into a multi-epitope vaccine with spacers and adjuvants to enhance the immune response. A 3D model was developed, confirming structural stability and optimal epitope exposure through molecular dynamics simulations. The results indicate that the vaccine can induce robust immune responses, suggesting its potential effectiveness against the Mpox virus. Additionally, population coverage analysis supports its promise as a significant tool for controlling Mpox epidemics and advancing global public health initiatives.
- Open Access
- 15 September 2024
- Published by Clinical Biotec S.L. in Bionatura Journal
- Vol. 1 (3) , 7
Candida auris: An Emerging Challenge in Clinical Mycology and Public Health in Latin America
Candida auris is an emerging fungus that poses a critical challenge in clinical mycology and global public health. Identified in 2005, this pathogen has caused hospital outbreaks due to its resistance to multiple antifungals and ability to persist in hospital settings. In Latin America, C. auris has been reported since 2012 in several countries, including a case in Ecuador in 2024. Its emergence has been linked to climate change and the excessive use of antifungals, which could be favoring its proliferation. The diagnosis of C. auris is complex and requires advanced methods such as MALDI-TOF mass spectrometry and molecular techniques due to its phenotypic variability. Another factor to be relevant to public health is resistance to conventional treatments. In addition, genomic surveillance is essential to understand the epidemiology of this pathogen and control its spread in hospital settings. Urgent prevention, detection, and treatment measures are necessary to limit the spread of C. auris in the region and minimize its impact on public health. Implementing comprehensive strategies, including genomic surveillance and advanced diagnostic techniques, is crucial to address this emerging problem in Latin America.
- 15 September 2024
- Published by Clinical Biotec S.L. in Bionatura Journal
- Vol. 1 (3) , 7
Open AccessCandida auris: An Emerging Challenge in Clinical Mycology and Public Health in Latin America
Candida auris is an emerging fungus that poses a critical challenge in clinical mycology and global public health. Identified in 2005, this pathogen has caused hospital outbreaks due to its resistance to multiple antifungals and ability to persist in hospital settings. In Latin America, C. auris has been reported since 2012 in several countries, including a case in Ecuador in 2024. Its emergence has been linked to climate change and the excessive use of antifungals, which could be favoring its proliferation. The diagnosis of C. auris is complex and requires advanced methods such as MALDI-TOF mass spectrometry and molecular techniques due to its phenotypic variability. Another factor to be relevant to public health is resistance to conventional treatments. In addition, genomic surveillance is essential to understand the epidemiology of this pathogen and control its spread in hospital settings. Urgent prevention, detection, and treatment measures are necessary to limit the spread of C. auris in the region and minimize its impact on public health. Implementing comprehensive strategies, including genomic surveillance and advanced diagnostic techniques, is crucial to address this emerging problem in Latin America.
- Open Access
- 15 September 2024
- Published by Clinical Biotec S.L.
- Vol. 1 (3) , 1-7
Candida auris: An Emerging Challenge in Clinical Mycology and Public Health in Latin America
Candida auris is an emerging fungus that poses a critical challenge in clinical mycology and global public health. Identified in 2005, this pathogen has caused hospital outbreaks due to its resistance to multiple antifungals and ability to persist in hospital settings. In Latin America, C. auris has been reported since 2012 in several countries, including a case in Ecuador in 2024. Its emergence has been linked to climate change and the excessive use of antifungals, which could be favoring its proliferation. The diagnosis of C. aurisis complex and requires advanced methods such as MALDI-TOF mass spectrometry and molecular techniques due to its phenotypic variability. Another factor to be relevant to public health is resistance to conventional treatments. In addition, genomic surveillance is essential to understand the epidemiology of this pathogen and control its spread in hospital settings. Urgent prevention, detection, and treatment measures are necessary to limit the spread of C. auris in the region and minimize its impact on public health. Implementing comprehensive strategies, including genomic surveillance and advanced diagnostic techniques, is crucial to address this emerging problem in Latin America. Keywords: Candida auris, Fungal infections, Antifungal resistance, Clinical mycology, Genomic surveillance, Latin America.
- 15 September 2024
- Published by Clinical Biotec S.L.
- Vol. 1 (3) , 1-7
Open AccessCandida auris: An Emerging Challenge in Clinical Mycology and Public Health in Latin America
Candida auris is an emerging fungus that poses a critical challenge in clinical mycology and global public health. Identified in 2005, this pathogen has caused hospital outbreaks due to its resistance to multiple antifungals and ability to persist in hospital settings. In Latin America, C. auris has been reported since 2012 in several countries, including a case in Ecuador in 2024. Its emergence has been linked to climate change and the excessive use of antifungals, which could be favoring its proliferation. The diagnosis of C. aurisis complex and requires advanced methods such as MALDI-TOF mass spectrometry and molecular techniques due to its phenotypic variability. Another factor to be relevant to public health is resistance to conventional treatments. In addition, genomic surveillance is essential to understand the epidemiology of this pathogen and control its spread in hospital settings. Urgent prevention, detection, and treatment measures are necessary to limit the spread of C. auris in the region and minimize its impact on public health. Implementing comprehensive strategies, including genomic surveillance and advanced diagnostic techniques, is crucial to address this emerging problem in Latin America. Keywords: Candida auris, Fungal infections, Antifungal resistance, Clinical mycology, Genomic surveillance, Latin America.
- Open Access
Genetic Variability in the E6/E7 Region of Human Papillomavirus 16 in Women from Ecuador
Human Papillomavirus (HPV) infection is associated with intraepithelial neoplasia and cervical cancer (CC). Ecuador has a high prevalence of cervical cancer, with more than 1600 new cases diagnosed annually. This study aimed to analyze oncogenes E6 and E7 of HPV16 in samples collected from women with cancerous and precancerous cervical lesions from the Ecuadorian coast. Twenty-nine women, including six with ASCUS, three with LSIL, thirteen with HSIL, and seven with Cacu, were analyzed. The most common SNPs were E6 350G or L83V (82.6%) and E6 145T/286A/289G/335T/350G or Q14H/F78Y/L83V (17.4%). Both variants are reported to be associated with an increased risk of cervical cancer in worldwide studies. In contrast, all E7 genes have conserved amino-acid positions. Phylogenetic trees showed the circulation of the D (26.1%) and A (73.9) lineages. The frequency of D was higher than that reported in other comparable studies in Ecuador and Latin America, and may be related to the ethnic composition of the studied populations. This study contributes to the characterization of the potential risk factors for cervical carcinogenesis associated with Ecuadorian women infected with HPV16.
Open AccessGenetic Variability in the E6/E7 Region of Human Papillomavirus 16 in Women from Ecuador
Human Papillomavirus (HPV) infection is associated with intraepithelial neoplasia and cervical cancer (CC). Ecuador has a high prevalence of cervical cancer, with more than 1600 new cases diagnosed annually. This study aimed to analyze oncogenes E6 and E7 of HPV16 in samples collected from women with cancerous and precancerous cervical lesions from the Ecuadorian coast. Twenty-nine women, including six with ASCUS, three with LSIL, thirteen with HSIL, and seven with Cacu, were analyzed. The most common SNPs were E6 350G or L83V (82.6%) and E6 145T/286A/289G/335T/350G or Q14H/F78Y/L83V (17.4%). Both variants are reported to be associated with an increased risk of cervical cancer in worldwide studies. In contrast, all E7 genes have conserved amino-acid positions. Phylogenetic trees showed the circulation of the D (26.1%) and A (73.9) lineages. The frequency of D was higher than that reported in other comparable studies in Ecuador and Latin America, and may be related to the ethnic composition of the studied populations. This study contributes to the characterization of the potential risk factors for cervical carcinogenesis associated with Ecuadorian women infected with HPV16.